Clinical Trial

Effects of Remimazolam on Postoperative Myocardial Injury

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
This study is designed as a prospective, double-blind, randomized controlled trial to investigate the effect of remimazolam on intraoperative cardiac output (CO) in elderly patients undergoing general anesthesia, and to evaluate its protective efficacy against elevated high-sensitivity cardiac troponin T (hs-cTnT) levels and perioperative myocardial injury.
Trial Details
NCT Number NCT07725185
Lead Sponsor Affiliated Hospital of Jiaxing University
Conditions Myocardial Injury
Enrollment 80 participants
Start Date 2026-08-01
Primary Completion 2028-06-01 (estimated)
Study Completion 2029-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-24